Pfizer and BioNTech have started its enrolment of participants in South Africa for its phase 3 COVID-19 vaccine trials.
Pfizer & BioNTech phase 3 COVID-19 vaccine trials resume in SA
PUBLISHED: Thu, 01 Oct 2020 11:18:03 GMT
News Tips
Got a confidential news tip? We want to hear from you.
Get In Touch
Advertise With Us
Please Contact Us
Newsletters
Sign up for free newsletters and get more CNBC Africa delivered to your inbox
Sign Up Now
Get this delivered to your inbox, and more info about our products and services.
© 2024 Africa Business News Pty. Ltd.
Data is a real-time snapshot *Data is delayed at least 15 minutes. African Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by 